The provision of quality health care requires a doctor-patient relationship of trust and confidentiality. Consistent with our commitment to quality care this practice has developed a policy to protect patient privacy in compliance with recent legislation.
It is necessary for us to collect personal information from patients and sometimes others associated with their health care in order to attend to their needs and for administrative purposes. In the interests of the highest quality and continuity of the patient’s health care this may also include sharing information with other health care providers who comprise a patient’s medical team from time to time.
Research is regularly carried out by medical specialists to assist in developing better treatment/cures for diseases. As a current full member of the Queensland Gynaecological Cancer QAC, as a consenting patient, data will be stored and processed relating to your condition/treatment for research and education purposes (note: patient identity will be withheld from any reports or publications), in addition, patient data will be reviewed regarding treatment outcomes in quality assurance programs at QCGC, to self-audit and further improve surgical performance.
Do you consent to Queensland Centre for Gynaecological Cancer (QCGC) storing your patient data for the purpose of research, education and to be reviewed in quality assurance programs to further improve patient outcomes?
As part of your care a gynaecological examination will generally be performed by your doctor. The precise nature of this examination will be discussed with you prior. Please advise the practice if you would prefer to have a support person present. It is important that you communicate with your doctor if you feel uncomfortable at any point during this examination, either from physical discomfort or modesty discomfort.
As part of the process of quality assurance, there is a weekly Clinico-Pathological meeting involving gynaecologic oncologists, radiation oncologists, medical oncologists and pathologists. At this meeting clinical information is presented on all patients treated for gynaecological cancer over the preceding week. Personal details are removed to ensure anonymity. The advantage of this meeting is the highest standards of peer review and the opportunity of multiple experienced opinions on each case of gynaecological malignancy. In some circumstances, a fully rebateable charge will be made for this multidisciplinary meeting – Medicare will be billed directly with no out of pocket expense for the patient.
This practice will also send a letter to all relevant health care providers detailing the treatment provided.
It is necessary for the staff to record your current height and weight measurements in order to calculate your BMI for research and clinical purposes.